Basic Information
HAEMOCTIN SDH 1000 FOR INJECTION 1000 iu/vial
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Regulatory Information
SIN15337P
October 4, 2017
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XB02BD02
Company Information
ESHCOL PHARMACEUTICAL GROUP SINGAPORE PTE LTD
GRIFOLS ASIA PACIFIC PTE. LTD.
Active Ingredients
Human coagulation factor VIII
Strength: 1000 iu/vial
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to the active substance or to any of the excipients.
Indication Information
**Indications** Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). This product may be used in the management of acquired factor VIII deficiency. This preparation does not contain von Willebrand factor in pharmacologically effective quantities and is therefore not indicated in von Willebrand's disease.